Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUCBMCs in Severe Acute Contusion Spinal Cord Injury
NCT04331405Phase 2Completed
- Sponsor
- Sklifosovsky Research Institute for Emergency Medicine
- Start
- Mar 2013
- Primary completion
- Mar 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human allogeneic umbilical cord blood mononuclear cells in spinal cord contusion, sponsored by Sklifosovsky Research Institute for Emergency Medicine. Started Mar 2013; status: completed.
02
Drugs
human allogeneic umbilical cord blood mononuclear cells
03
Conditions
spinal cord contusion
Beyond the preview
Go deeper on NCT04331405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04331405.